LVCAS9NEO

Cas9 Neomycin Lenti Particles

• Synonym(e): Lenti Particles
• UNSPSC-Code: 41106609
• NACRES: NA.51

Eigenschaften

• Verpackung: vial of 200 μL
• Qualitätsniveau: 200
• Konzentration: ≥1 x 10 ⁶ VP/ml virus (via p24 assay)
• Anwendung(en): CRISPR
• selection: neomycin / G418
• Versandbedingung: dry ice
• Lagertemp.: −70°C

Beschreibung

Allgemeine Beschreibung

Ready-to-use Cas9 lentiviral particles are ideal for transducing a wide range of cell lines. The Cas9 Neomycin Lentiviral particles efficiently integrate Cas9 into the genomes of both dividing and non-dividing cell lines for use with CRISPR genome editing. Stably integrate Cas9 and Neo using the convenient, ready-to-use lentiviral particles while avoiding the tedious lentivirus production process.

Anwendung

Functional Genomics/Screening /Target Validation/Genome Editing

Komponenten

200 ul of purified lentiviral particles (minimum of 1 X 10⁶ TU/ml via a p24 assay) expressing Cas9 only with blasticidin resistance.

Verlinkung

Click here to order gRNA plasmid and virus.

Sicherheitshinweise

• Lagerklassenschlüssel: 12 - Non Combustible Liquids
• WGK: WGK 3
• Flammpunkt (°F): Not applicable
• Flammpunkt (°C): Not applicable